Results 141 to 150 of about 458,168 (201)

Pathology and new insights in thyroid neoplasms in the 2022 WHO classification. [PDF]

Curr Opin Oncol
Lebrun L, Salmon I.
europepmc   +1 more source

European perspective on the use of molecular tests in the diagnosis and therapy of thyroid neoplasms. [PDF]

Gland Surg, 2020
Oczko-Wojciechowska M, Kotecka-Blicharz A, Krajewska J, Rusinek D, Barczyński M, Jarząb B, Czarniecka A.   +6 more
europepmc   +1 more source

Comparison of ultrasound findings of papillary thyroid carcinoma subtypes based on the 2022 WHO classification of thyroid neoplasms. [PDF]

Front Endocrinol (Lausanne)
Hekimsoy İ, Ertan Y, Serin G, Karabulut AK, Özbek SS.   +4 more
europepmc   +1 more source

Trends in Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features and Total Thyroidectomies for Patients With Papillary Thyroid Neoplasms.

JAMA Otolaryngol Head Neck Surg, 2022
Caulley L, Eskander A, Yang W, Auh E, Cairncross L, Cho NL, Golbon B, Iyer S, Liu JC, Lee PJ, Lindeman B, Meltzer C, Molin N, Moore A, Noel J, Nozolino H, Pasternak J, Price B, Ramsay T, Rolighed L, Sajisevi M, Sharma A, Sinclair C, Sorensen M, Tae K, Tang AL, Tsao G, Williams M, Wrenn S, Xing MH, Zafereo M, Stack BC, Randolph G, Davies L.   +33 more
europepmc   +1 more source

The Role of 5-Hydroxymethylcytosine as a Potential Epigenetic Biomarker in a Large Series of Thyroid Neoplasms. [PDF]

Endocr Pathol
Canberk S, Gonçalves J, Rios E, Povoa AA, Tastekin E, Sobrinho-Simões M, Uguz A, Aydin O, Ince U, Soares P, Máximo V.   +10 more
europepmc   +1 more source

Rare Thyroid Diseases Mimicking or Concealing Primitive Thyroid Neoplasms: A Call for a "Check and Double-Check" Clinical Mindset. [PDF]

Cureus
Duhamel F, Balti E, Waelput W, Raeymaeckers S, Verfaillie G, Luyten I, Andreescu CE.   +6 more
europepmc   +1 more source

Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions. [PDF]

Int J Mol Sci
Denti V, Greco A, Alviano AM, Capitoli G, Monza N, Smith A, Pilla D, Maggioni A, Ivanova M, Venetis K, Maffini F, Garancini M, Pincelli AI, Galimberti S, Magni F, Fusco N, L'Imperio V, Pagni F.   +17 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neoplasm of the Thyroid Gland

Clinics in Geriatric Medicine, 1995
Although the prevalence of thyroid nodule is approximately 1% to 5% in the general adult population, 6% to 10% of older persons may have solitary nodules. Between 2% and 10% of thyroid nodules are noted to be carcinomatous. Approximately 1200 persons die of thyroid carcinoma each year in the United States alone; the incidence is much higher in women ...
openaire   +2 more sources

UNUSUAL TYPES OF THYROID NEOPLASMS

Endocrinology and Metabolism Clinics of North America, 1996
This article discusses several unusual forms of primary thyroid neoplasms. The TCV of PTC and insular thyroid carcinoma appears to have a more aggressive clinical behavior than DTC in most patient groups and may respond to thyroid hormone suppression and radioiodine.
K D, Burman, M D, Ringel, L, Wartofsky
openaire   +2 more sources

Hurthle Cell Neoplasms of the Thyroid

The Laryngoscope, 2002
AbstractObjectives/Hypothesis Hurthle cell tumors are a variant of follicular cell neoplasms. The purpose of the study was to determine the reliability of intraoperative frozen‐section analysis for diagnosing Hurthle cell carcinoma and Hurthle cell neoplasm and to evaluate age, gender, and tumor size differences in the incidence of Hurthle cell ...
Linda D, Dahl, David, Myssiorek, Keith S, Heller   +2 more
openaire   +2 more sources